These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33692855)

  • 1. NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer.
    Dong M; Xu T; Cui X; Li H; Li X; Xia W
    Oncol Lett; 2021 Apr; 21(4):323. PubMed ID: 33692855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer.
    Lou W; Liu J; Ding B; Jin L; Xu L; Li X; Chen J; Fan W
    Aging (Albany NY); 2019 May; 11(9):2628-2652. PubMed ID: 31058608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-23b-3p targets non-SMC condensing I complex subunit G to promote proliferation and inhibit apoptosis of colorectal cancer cells via regulation of the PI3K/AKT signaling pathway.
    Li P; Wen J; Ren X; Zhou Y; Xue Y; Yan Z; Li S; Tian H; Tang XG; Zhang GJ
    Oncol Lett; 2021 Dec; 22(6):812. PubMed ID: 34671426
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang X; Wang H; Han Y; Zhu M; Song Z; Zhan D; Jia J
    Onco Targets Ther; 2020; 13():11315-11326. PubMed ID: 33177839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1/lncRNA TYMSOS/miR-214-3p-Mediated High Expression of NCAPG Correlates With Poor Prognosis and Cell Proliferation in Non-Small Cell Lung Carcinoma.
    Yuan Y; Jiang X; Tang L; Wang J; Zhang D; Cho WC; Duan L
    Front Mol Biosci; 2021; 8():785767. PubMed ID: 35211508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of NCAPG mediated by E2F1 facilitates the progression of osteosarcoma through the Wnt/β-catenin signaling pathway.
    Luo G; Cheng H; Fan J; Sun T
    Transl Cancer Res; 2024 May; 13(5):2437-2450. PubMed ID: 38881929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway.
    Wu Y; Lin Y; Pan J; Tu X; Xu Y; Li H; Chen Y
    Cancer Cell Int; 2021 Aug; 21(1):443. PubMed ID: 34419073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.
    Xu T; Dong M; Wang Z; Li H; Li X
    Cancer Manag Res; 2020; 12():5773-5786. PubMed ID: 32765080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
    Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H
    Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway.
    Tang F; Yu H; Wang X; Shi J; Chen Z; Wang H; Wan Z; Fu Q; Hu X; Zuhaer Y; Liu T; Yang Z; Peng J
    Biochem Biophys Res Commun; 2022 Sep; 622():101-107. PubMed ID: 35843088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCAPG as a Novel Prognostic Biomarker in Glioma.
    Jiang X; Shi Y; Chen X; Xu H; Liu B; Zhou F; Huang X; Cho WC; Li L; Pu J
    Front Oncol; 2022; 12():831438. PubMed ID: 35280743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma.
    Bao J; Wu Y; Zhang K; Qi H
    Int J Gen Med; 2022; 15():6917-6930. PubMed ID: 36061963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells.
    Liu K; Li Y; Yu B; Wang F; Mi T; Zhao Y
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1246-1254. PubMed ID: 30089216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
    Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
    Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer.
    Sun DP; Lin CC; Hung ST; Kuang YY; Hseu YC; Fang CL; Lin KY
    Cancer Manag Res; 2020; 12():7837-7846. PubMed ID: 32922082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NCAPG in various of tumors.
    Cai X; Gao J; Shi C; Guo WZ; Guo D; Zhang S
    Biomed Pharmacother; 2022 Nov; 155():113635. PubMed ID: 36095957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma.
    Liu W; Liang B; Liu H; Huang Y; Yin X; Zhou F; Yu X; Feng Q; Li E; Zou Z; Wu L
    Int J Mol Med; 2017 Sep; 40(3):731-738. PubMed ID: 28737823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCAPG Is a Promising Therapeutic Target Across Different Tumor Types.
    Xiao C; Gong J; Jie Y; Cao J; Chen Z; Li R; Chong Y; Hu B; Zhang Q
    Front Pharmacol; 2020; 11():387. PubMed ID: 32300299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer.
    Lou W; Ding B; Fan W
    Mol Ther Oncolytics; 2019 Sep; 14():15-26. PubMed ID: 31011629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.